Lectin-like transcript 1 is a marker of germinal center-derived B-cell non-Hodgkin's lymphomas dampening natural killer cell functions

References

• Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program 2009:523-31; PMID:20008237; http://dx.doi.org/10.1182/asheducation-2009.1.523
   Google Scholar
• Turner JJ, Morton LM, Linet MS, Clarke CA, Kadin ME, Vajdic CM, Monnereau A, Maynadié M, Chiu BC, Marcos-Gragera R et al. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood 2010; 116:e90-8; PMID:20699439; http://dx.doi.org/10.1182/blood-2010-06-289561
   PubMed Web of Science ®Google Scholar
• Shaffer AL, 3rd, Young RM, Staudt LM. Pathogenesis of human B cell lymphomas. Annu Rev Immunol 2012; 30:565-610; PMID:22224767; http://dx.doi.org/10.1146/annurev-immunol-020711-075027
   PubMed Web of Science ®Google Scholar
• Motta G, Cea M, Moran E, Carbone F, Augusti V, Patrone F, Nencioni A. Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives. Clin Dev Immunol 2010; 2010:428253; PMID:21437222; http://dx.doi.org/10.1155/2010/428253
   PubMedGoogle Scholar
• Henry C, Deschamps M, Rohrlich PS, Pallandre JR, Remy-Martin JP, Callanan M, Traverse-Glehen A, GrandClément C, Garnache-Ottou F, Gressin R et al. Identification of an alternative CD20 transcript variant in B-cell malignancies coding for a novel protein associated to rituximab resistance. Blood 2010; 115:2420-9; PMID:20089966; http://dx.doi.org/10.1182/blood-2009-06-229112
   PubMed Web of Science ®Google Scholar
• McLaughlin P, Grillo-Lopez AJ, Link BK, Levy R, Czuczman MS, Williams ME, Heyman MR, Bence-Bruckler I, White CA, Cabanillas F et al. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol 1998; 16:2825-33; PMID:9704735
   PubMed Web of Science ®Google Scholar
• Czuczman MS, Olejniczak S, Gowda A, Kotowski A, Binder A, Kaur H, Knight J, Starostik P, Deans J, Hernandez-Ilizaliturri FJ. Acquirement of rituximab resistance in lymphoma cell lines is associated with both global CD20 gene and protein down-regulation regulated at the pretranscriptional and posttranscriptional levels. Clin Cancer Res 2008; 14:1561-70; PMID:18316581; http://dx.doi.org/10.1158/1078-0432.CCR-07-1254
   PubMed Web of Science ®Google Scholar
• Kuppers R, Klein U, Hansmann ML, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med 1999; 341:1520-9; PMID:10559454; http://dx.doi.org/10.1056/NEJM199911113412007
   PubMed Web of Science ®Google Scholar
• Stevenson F, Sahota S, Zhu D, Ottensmeier C, Chapman C, Oscier D, Hamblin T. Insight into the origin and clonal history of B-cell tumors as revealed by analysis of immunoglobulin variable region genes. Immunol Rev 1998; 162:247-59; PMID:9602369; http://dx.doi.org/10.1111/j.1600-065X.1998.tb01446.x
   PubMed Web of Science ®Google Scholar
• Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403:503-11; PMID:10676951; http://dx.doi.org/10.1038/35000501
   PubMed Web of Science ®Google Scholar
• Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002; 346:1937-47; PMID:12075054; http://dx.doi.org/10.1056/NEJMoa012914
   PubMed Web of Science ®Google Scholar
• Dunn GP, Koebel CM, Schreiber RD. Interferons, immunity and cancer immunoediting. Nat Rev Immunol 2006; 6:836-48; PMID:17063185; http://dx.doi.org/10.1038/nri1961
   PubMed Web of Science ®Google Scholar
• Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012; 12:252-64; PMID:22437870; http://dx.doi.org/10.1038/nrc3239
   PubMed Web of Science ®Google Scholar
• Ame-Thomas P, Tarte K. The yin and the yang of follicular lymphoma cell niches: role of microenvironment heterogeneity and plasticity. Semin Cancer Biol 2014; 24:23-32; PMID:23978491; http://dx.doi.org/10.1016/j.semcancer.2013.08.001
   PubMed Web of Science ®Google Scholar
• Kridel R, Sehn LH, Gascoyne RD. Pathogenesis of follicular lymphoma. J Clin Invest 2012; 122:3424-31; PMID:23023713; http://dx.doi.org/10.1172/JCI63186
   PubMed Web of Science ®Google Scholar
• Scott DW, Gascoyne RD. The tumour microenvironment in B cell lymphomas. Nat Rev Cancer 2014; 14:517-34; PMID:25008267; http://dx.doi.org/10.1038/nrc3774
   PubMed Web of Science ®Google Scholar
• Thieblemont C, Delfau-Larue MH, Coiffier B. Lenalidomide in diffuse large B-cell lymphoma. Adv Hematol 2012; 2012:861060; PMID:23251161; http://dx.doi.org/10.1155/2012/861060
   PubMedGoogle Scholar
• List AF, Spier CM, Miller TP, Grogan TM. Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetence. Leukemia 1993; 7:398-403; PMID:7680400
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Trifonov V, Fabbri G, Ma J, Rossi D, Chiarenza A, Wells VA, Grunn A, Messina M, Elliot O et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 2011; 43:830-7; PMID:21804550; http://dx.doi.org/10.1038/ng.892
   PubMed Web of Science ®Google Scholar
• Ramsay AG, Clear AJ, Kelly G, Fatah R, Matthews J, Macdougall F, Lister TA, Lee AM, Calaminici M, Gribben JG. Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy. Blood 2009; 114:4713-20; PMID:19786615; http://dx.doi.org/10.1182/blood-2009-04-217687
   PubMed Web of Science ®Google Scholar
• Yang ZZ, Grote DM, Ziesmer SC, Niki T, Hirashima M, Novak AJ, Witzig TE, Ansell SM. IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma. J Clin Invest 2012; 122:1271-82; PMID:22426209; http://dx.doi.org/10.1172/JCI59806
   PubMed Web of Science ®Google Scholar
• Yang ZZ, Novak AJ, Stenson MJ, Witzig TE, Ansell SM. Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood 2006; 107:3639-46; PMID:16403912; http://dx.doi.org/10.1182/blood-2005-08-3376
   PubMed Web of Science ®Google Scholar
• Lee NR, Song EK, Jang KY, Choi HN, Moon WS, Kwon K, Lee JH, Yim CY, Kwak JY. Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis. Leuk Lymphoma 2008; 49:247-56; PMID:18231910; http://dx.doi.org/10.1080/10428190701824536
   PubMed Web of Science ®Google Scholar
• Ame-Thomas P, Le Priol J, Yssel H, Caron G, Pangault C, Jean R, Martin N, Marafioti T, Gaulard P, Lamy T et al. Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells. Leukemia 2012; 26:1053-63; PMID:22015774; http://dx.doi.org/10.1038/leu.2011.301
   PubMed Web of Science ®Google Scholar
• Gertner-Dardenne J, Fauriat C, Orlanducci F, Thibult ML, Pastor S, Fitzgibbon J, Bouabdallah R, Xerri L, Olive D. The co-receptor BTLA negatively regulates human Vgamma9Vdelta2 T-cell proliferation: a potential way of immune escape for lymphoma cells. Blood 2013; 122:922-31; PMID:23692853; http://dx.doi.org/10.1182/blood-2012-11-464685
   PubMed Web of Science ®Google Scholar
• Xerri L, Chetaille B, Serriari N, Attias C, Guillaume Y, Arnoulet C, Olive D. Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia. Hum Pathol 2008; 39:1050-8; PMID:18479731; http://dx.doi.org/10.1016/j.humpath.2007.11.012
   PubMed Web of Science ®Google Scholar
• Sedy JR, Gavrieli M, Potter KG, Hurchla MA, Lindsley RC, Hildner K, Scheu S, Pfeffer K, Ware CF, Murphy TL et al. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol 2005; 6:90-8; PMID:15568026; http://dx.doi.org/10.1038/ni1144
   PubMed Web of Science ®Google Scholar
• Cartron G, Dacheux L, Salles G, Solal-Celigny P, Bardos P, Colombat P, Watier H. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. Blood 2002; 99:754-8; PMID:11806974; http://dx.doi.org/10.1182/blood.V99.3.754
   PubMed Web of Science ®Google Scholar
• Clynes RA, Towers TL, Presta LG, Ravetch JV. Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets. Nat Med 2000; 6:443-6; PMID:10742152; http://dx.doi.org/10.1038/74704
   PubMed Web of Science ®Google Scholar
• Aldemir H, Prod'homme V, Dumaurier MJ, Retiere C, Poupon G, Cazareth J, Bihl F, Braud VM. Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor. J Immunol 2005; 175:7791-5; PMID:16339512; http://dx.doi.org/10.4049/jimmunol.175.12.7791
   PubMed Web of Science ®Google Scholar
• Rosen DB, Bettadapura J, Alsharifi M, Mathew PA, Warren HS, Lanier LL. Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor. J Immunol 2005; 175:7796-9; PMID:16339513; http://dx.doi.org/10.4049/jimmunol.175.12.7796
   PubMed Web of Science ®Google Scholar
• Germain C, Meier A, Jensen T, Knapnougel P, Poupon G, Lazzari A, Neisig A, Håkansson K, Dong T, Wagtmann N et al. Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-gamma contributes to modulate immune responses. J Biol Chem 2011; 286:37964-75; PMID:21930700; http://dx.doi.org/10.1074/jbc.M111.285312
   PubMed Web of Science ®Google Scholar
• Germain C, Bihl F, Zahn S, Poupon G, Dumaurier MJ, Rampanarivo HH, Padkjær SB, Spee P, Braud VM. Characterization of Alternatively Spliced Transcript Variants of CLEC2D Gene. J Biol Chem 2010; 285:36207-15; PMID:20843815; http://dx.doi.org/10.1074/jbc.M110.179622
   PubMed Web of Science ®Google Scholar
• van Zelm MC, Szczepanski T, van der Burg M, van Dongen JJ. Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion. J Exp Med 2007; 204:645-55; PMID:17312005; http://dx.doi.org/10.1084/jem.20060964
   PubMed Web of Science ®Google Scholar
• Caron G, Le Gallou S, Lamy T, Tarte K, Fest T. CXCR4 expression functionally discriminates centroblasts versus centrocytes within human germinal center B cells. J Immunol 2009; 182:7595-602; PMID:19494283; http://dx.doi.org/10.4049/jimmunol.0804272
   PubMed Web of Science ®Google Scholar
• Victora GD, Dominguez-Sola D, Holmes AB, Deroubaix S, Dalla-Favera R, Nussenzweig MC. Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas. Blood 2012; 120:2240-8; PMID:22740445; http://dx.doi.org/10.1182/blood-2012-03-415380
   PubMed Web of Science ®Google Scholar
• Fergusson JR, Smith KE, Fleming VM, Rajoriya N, Newell EW, Simmons R, Marchi E, Björkander S, Kang YH, Swadling L et al. CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages. Cell Rep 2014; 9:1075-88; PMID:25437561; http://dx.doi.org/10.1016/j.celrep.2014.09.045
   PubMed Web of Science ®Google Scholar
• Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708-12; PMID:10537110; http://dx.doi.org/10.1038/44385
   PubMed Web of Science ®Google Scholar
• Takahashi T, Dejbakhsh-Jones S, Strober S. Expression of CD161 (NKR-P1A) defines subsets of human CD4 and CD8 T cells with different functional activities. J Immunol 2006; 176:211-6; PMID:16365412; http://dx.doi.org/10.4049/jimmunol.176.1.211
   PubMed Web of Science ®Google Scholar
• Ueno H, Banchereau J, Vinuesa CG. Pathophysiology of T follicular helper cells in humans and mice. Nat Immunol 2015; 16:142-52; PMID:25594465; http://dx.doi.org/10.1038/ni.3054
   PubMed Web of Science ®Google Scholar
• Visco C, Li Y, Xu-Monette ZY, Miranda RN, Green TM, Tzankov A, Wen W, Liu WM, Kahl BS, d'Amore ES et al. Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Leukemia 2012; 26:2103-13; PMID:22437443; http://dx.doi.org/10.1038/leu.2012.83
   PubMed Web of Science ®Google Scholar
• Coutinho R, Clear AJ, Owen A, Wilson A, Matthews J, Lee A, Alvarez R, Gomes da Silva M, Cabeçadas J, Calaminici M et al. Poor concordance among nine immunohistochemistry classifiers of cell-of-origin for diffuse large B-cell lymphoma: implications for therapeutic strategies. Clin Cancer Res 2013; 19:6686-95; PMID:24122791; http://dx.doi.org/10.1158/1078-0432.CCR-13-1482
   PubMed Web of Science ®Google Scholar
• Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A, Staudt LM. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci U S A 2003; 100:9991-6; PMID:12900505; http://dx.doi.org/10.1073/pnas.1732008100
   PubMed Web of Science ®Google Scholar
• Liu H, Bebu I, Li X. Microarray probes and probe sets. Front Biosci (Elite Ed) 2010; 2:325-38; PMID:20036881; http://dx.doi.org/10.2741/e93
   PubMedGoogle Scholar
• Liu H, Zeeberg BR, Qu G, Koru AG, Ferrucci A, Kahn A, Ryan MC, Nuhanovic A, Munson PJ, Reinhold WC et al. AffyProbeMiner: a web resource for computing or retrieving accurately redefined Affymetrix probe sets. Bioinformatics 2007; 23:2385-90; PMID:17660211; http://dx.doi.org/10.1093/bioinformatics/btm360
   PubMed Web of Science ®Google Scholar
• Monti S, Savage KJ, Kutok JL, Feuerhake F, Kurtin P, Mihm M, Wu B, Pasqualucci L, Neuberg D, Aguiar RC et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 2005; 105:1851-61; PMID:15550490; http://dx.doi.org/10.1182/blood-2004-07-2947
   PubMed Web of Science ®Google Scholar
• Westin JR, Chu F, Zhang M, Fayad LE, Kwak LW, Fowler N, Romaguera J, Hagemeister F, Fanale M, Samaniego F et al. Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial. Lancet Oncol 2014; 15:69-77; PMID:24332512; http://dx.doi.org/10.1016/S1470-2045(13)70551-5
   PubMed Web of Science ®Google Scholar
• Exley M, Garcia J, Balk SP, Porcelli S. Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells. J Exp Med 1997; 186:109-20; PMID:9207002; http://dx.doi.org/10.1084/jem.186.1.109
   PubMed Web of Science ®Google Scholar
• Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM. Control of inflammation, cytokine expression, and germinal center formation by BCL−6. Science 1997; 276:589-92; PMID:9110977; http://dx.doi.org/10.1126/science.276.5312.589
   PubMed Web of Science ®Google Scholar
• Fukuda T, Yoshida T, Okada S, Hatano M, Miki T, Ishibashi K, Okabe S, Koseki H, Hirosawa S, Taniguchi M et al. Disruption of the Bcl6 gene results in an impaired germinal center formation. J Exp Med 1997; 186:439-48; PMID:9236196; http://dx.doi.org/10.1084/jem.186.3.439
   PubMed Web of Science ®Google Scholar
• Ye BH, Cattoretti G, Shen Q, Zhang J, Hawe N, de Waard R, Leung C, Nouri-Shirazi M, Orazi A, Chaganti RS et al. The BCL−6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet 1997; 16:161-70; PMID:9171827; http://dx.doi.org/10.1038/ng0697-161
   PubMed Web of Science ®Google Scholar
• Victora GD, Nussenzweig MC. Germinal centers. Annu Rev Immunol 2012; 30:429-57; PMID:22224772; http://dx.doi.org/10.1146/annurev-immunol-020711-075032
   PubMed Web of Science ®Google Scholar
• Klein U, Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 2008; 8:22-33; PMID:18097447; http://dx.doi.org/10.1038/nri2217
   PubMed Web of Science ®Google Scholar
• DeFranco AL, Rookhuizen DC, Hou B. Contribution of Toll-like receptor signaling to germinal center antibody responses. Immunol Rev 2012; 247:64-72; PMID:22500832; http://dx.doi.org/10.1111/j.1600-065X.2012.01115.x
   PubMed Web of Science ®Google Scholar
• Hou B, Saudan P, Ott G, Wheeler ML, Ji M, Kuzmich L, Lee LM, Coffman RL, Bachmann MF, DeFranco AL. Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response. Immunity 2011; 34:375-84; PMID:21353603; http://dx.doi.org/10.1016/j.immuni.2011.01.011
   PubMed Web of Science ®Google Scholar
• Travert M, Ame-Thomas P, Pangault C, Morizot A, Micheau O, Semana G, Lamy T, Fest T, Tarte K, Guillaudeux T. CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl−xL. J Immunol 2008; 181:1001-11; PMID:18606651; http://dx.doi.org/10.4049/jimmunol.181.2.1001
   PubMed Web of Science ®Google Scholar
• Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Müller-Hermelink HK, Campo E, Braziel RM, Jaffe ES et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103:275-82; PMID:14504078; http://dx.doi.org/10.1182/blood-2003-05-1545
   PubMed Web of Science ®Google Scholar
• Jedema I, van der Werff NM, Barge RM, Willemze R, Falkenburg JH. New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population. Blood 2004; 103:2677-82; PMID:14630824; http://dx.doi.org/10.1182/blood-2003-06-2070
   PubMed Web of Science ®Google Scholar